Insider Shareholders with Direct Ownership of Immunity Bio, Inc. (IBRX)
This section provides a comprehensive overview of the insiders with direct ownership of Immunity Bio, Inc. (IBRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ImmunityBio, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Patrick Soon Shiong
Director |
5,723,182 | 0 | 29,473,932 $150 Million | 1 |
Mar 09, 2021
Added 16.26%
|
Barry J. Simon
Director |
453,466 | 429,194 | 3,123,761 $15.9 Million | 17 |
Jan 31, 2024
Reduced 0.7%
|
Richard Adcock
CEO & President |
451,723 | 208,585 | 243,138 $1.24 Million | 14 |
Feb 05, 2024
Reduced 15.08%
|
John C Thomas
Director |
0 | 42,592 | 207,477 $1.06 Million | 1 |
Dec 10, 2020
Reduced 17.03%
|
Cheryl Cohen
Director |
0 | 70,308 | 200,617 $1.02 Million | 4 |
Aug 23, 2021
Reduced 6.87%
|
David C. Sachs
Chief Financial Officer |
204,324 | 37,346 | 185,838 $947,773 | 8 |
Jan 31, 2024
Reduced 12.62%
|
Regan J Lauer
Chief Accounting Officer |
107,804 | 13,470 | 94,334 $481,103 | 5 |
Jan 31, 2024
Reduced 12.49%
|
John Owen Brennan
Director |
25,000 | 0 | 25,000 $127,499 | 1 |
Jun 02, 2023
Added 28.57%
|
Sonja Nelson
Chief Financial Officer |
34,093 | 55,635 | 15,410 $78,591 | 4 |
Jan 12, 2021
Reduced 51.5%
|
Wesley Clark
Director |
7,000 | 0 | 8,000 $40,800 | 1 |
Jun 01, 2023
Added 46.67%
|